Global Cord Blood Corp Files 6-K, Notes Cayman Court Appointment
| Field | Detail |
|---|---|
| Company | Global Cord Blood Corp |
| Form Type | 6-K |
| Filed Date | Sep 2, 2025 |
| Risk Level | low |
| Pages | 1 |
| Reading Time | 1 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: legal-update, corporate-action, foreign-issuer
TL;DR
GCBC filed a 6-K, mentioning a Cayman Islands court appointment from 2022. No major financial news.
AI Summary
Global Cord Blood Corporation filed a Form 6-K on September 2, 2025, reporting on events for the month of September 2025. The filing includes an introductory note stating that on September 22, 2022, the Grand Court of the Cayman Islands appointed Margot MacInnis. The company's principal executive offices are located at 48th Floor, Bank of China Tower, 1 Garden Road, Central, Hong Kong S.A.R.
Why It Matters
This filing provides an update on corporate actions and legal proceedings involving Global Cord Blood Corporation, potentially impacting investor understanding of the company's governance and operational status.
Risk Assessment
Risk Level: low — The filing is primarily procedural and informational, with no immediate financial or operational risks disclosed.
Key Players & Entities
- Global Cord Blood Corporation (company) — Registrant
- Margot MacInnis (person) — Appointed by Grand Court of the Cayman Islands
- Grand Court of the Cayman Islands (company) — Court that issued an order
- September 22, 2022 (date) — Date of court order
- September 2, 2025 (date) — Filing date
FAQ
What was the purpose of the court order mentioned in the filing?
The filing states that on September 22, 2022, the Grand Court of the Cayman Islands issued an order appointing Margot MacInnis, but does not specify the purpose of this appointment.
Is this filing related to recent financial performance?
This Form 6-K is a report of foreign private issuer and does not appear to contain specific financial performance data for the current period; it primarily notes a past court appointment and provides company address details.
What is the company's primary business?
Global Cord Blood Corporation is classified under SERVICES-MISC HEALTH & ALLIED SERVICES, NEC [8090].
Where are Global Cord Blood Corporation's principal executive offices located?
The company's principal executive offices are located at 48th Floor, Bank of China Tower, 1 Garden Road, Central, Hong Kong S.A.R.
Has the company changed its name previously?
Yes, the company was formerly known as China Cord Blood Corp, with a date of name change on July 7, 2009.
Filing Stats: 327 words · 1 min read · ~1 pages · Grade level 13.5 · Accepted 2025-09-02 16:15:44
Filing Documents
- form6k.htm (6-K) — 13KB
- 0000929638-25-003328.txt ( ) — 14KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. GLOBAL CORD BLOOD CORPORATION By: /s/ John Royle Name: John Royle Title: Joint Provisional Liquidator by Order of the Grand Court of the Cayman Islands Dated: September 2, 2025